{
  "num_tested_probands": 4,
  "num_positive_het_probands": 0,
  "positive_phenotypes": [
    "early developmental delay",
    "motor weakness",
    "intellectual disability",
    "severe progressive encephalopathy",
    "epileptic seizure",
    "acute liver failure",
    "mild dysmorphic facial features",
    "intra-uterine growth retardation",
    "severe axial hypotonia",
    "hypertonia",
    "dystonic posturing of arms and legs",
    "slight dysmorphic features",
    "severe delay of cognitive and motor development",
    "optic atrophy",
    "acute liver failure (ALF)",
    "metabolic encephalopathy",
    "severe generalized amyotrophy",
    "seizures",
    "severe encephalopathy",
    "deteriorated rapidly",
    "became progressively more unconscious and died half a year later",
    "epilepsy",
    "ptosis",
    "hypoglycaemia",
    "valproate induced hepatotoxicity",
    "atrophy most prominent in the frontal regions",
    "atrophy of the vermis cerebelli",
    "brainstem and cerebellar peduncles atrophy"
  ],
  "num_compound_or_double_hets": 4,
  "explanation": {
    "num_tested_probands": "Pages 1-2, 3-4, 5-6, and 7-8 each describe a single proband tested.",
    "num_positive_het_probands": "No explicit mention of heterozygous probands for a single pathogenic variant was found in any section.",
    "positive_phenotypes": "Phenotypes were extracted from explicit and inferred descriptions across pages 1-8.",
    "num_compound_or_double_hets": "Pages 1-2, 3-4, 5-6, and 7-8 each describe compound heterozygous mutations in the proband."
  }
}